Article18 1

Global Biotech Monthly special report: Intestinal microbes are the key puzzle of precision medicine

This issue of Global Biotech Monthly features a special article introducing the global precision medicine industry. In an interview, Leeuwenhoek CEO Associate Professor Xu Chengzhi introduced the relationship between intestinal microorganisms and chronic metabolic diseases, and introduced Leeuwenhoek's unique one-stop service for intestinal bacteria-targeted precision medicine.

Article18 1

Image source: Global Biotech Monthly

Full report:

Original URL: https://news.gbimonthly.com/tw/magazine/article_show.php?num=66243&menu=1461&p_id=122

Lwhk Favicon

Leeuwenhoek Biotech

Leeuwenhoek Biotech Inc. is a spin-off startup of the National Taiwan University. Since its establishment in August 2011, it has established three laboratories and is dedicated to providing the most professional microbial polysomics technology services to academic research units and the industry. It possesses key technologies such as mass spectrometry metabolome analysis and sterile mouse experiments, in order to promote human health and accelerate the development of precision medicine.

Related Posts